Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease

Brian Finan, Christoffer Clemmensen, Zhimeng Zhu, Kerstin Stemmer, Karine Gauthier, Luisa Müller, Meri De Angelis, Kristin Moreth, Frauke Neff, Diego Perez-Tilve, Katrin Fischer, Dominik Lutter, Miguel A. Sánchez-Garrido, Peng Liu, Jan Tuckermann, Mohsen Malehmir, Marc E. Healy, Achim Weber, Mathias Heikenwalder, Martin JastrochMaximilian Kleinert, Sigrid Jall, Sara Brandt, Frédéric Flamant, Karl Werner Schramm, Heike Biebermann, Yvonne Döring, Christian Weber, Kirk M Habegger, Michaela Keuper, Vasily Gelfanov, Fa Liu, Josef Köhrle, Jan Rozman, Helmut Fuchs, Valérie Gailus-Durner, Martin Hrabě de Angelis, Susanna M Hofmann, Bin Yang, Matthias H Tschöp, Richard Dimarchi, Timo D Müller

100 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds